Skip to content

Comparing the efficacy of chakramardabeeja lepa with shirishtwak lepa in dadru Tinea corporis especially in children

Evaluation of Comparative Efficacy of Chakramardabeeja Lepa against Shirishtwak Lepa in Dadru (Tinea Corporis) in Children - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/12/060867
Enrollment
60
Registered
2023-12-28
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B354- Tinea corporis

Interventions

None listed

Sponsors

Mahatma Gandhi Ayurveda College Hospital and Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient willing to give written informed consent with either gender having age of 03 to 15 years and patients Parents willing to allow their child to participate with Clinically diagnosed Dadru (Tinea Corporis)

Exclusion criteria

Exclusion criteria: Patients who have had a long-term Dadru Kushtha infection and with additional skin conditions and Having serious systemic illnesses such as HIV TB systemic lupus erythematosus

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of Chakramardabeeja Lepa in Dadru (Tinea Corporis) in Children of 3 year to 15 years by gradation scale parameter with number and size of patchesTimepoint: at 7th, 15th days

Secondary

MeasureTime frame
To evaluate the efficacy of shirishtwak Lepa in Dadru (Tinea Corporis) in Children of 3 to 15 years of age by gradation scale of numbers & sizes of patchesTimepoint: at 1st , 2nd week

Countries

India

Contacts

Public ContactPrasad Ramesh Barase

Mahatma Gandhi Ayurveda College Hospital and Research Centre

rahul.jumle@gmail.com9766643990

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026